Medscape www.medscape.com

References for:
Not So Rare: Errors of Metabolism During the Neonatal Period

[NBIN 3(4):143-155, 2003. © 2003 W.B. Saunders]

  1. Enns GM, Steiner RD. Diagnosis and treatment of children with suspected metabolic disease. Compr Pediatr (in press)
  2. Nyhan WL, Ozand PT: Atlas of Metabolic Diseases. London, UK, Chapman & Hall, 1998
  3. Rimoin DL, Connor JM, Pyeritz RE: Emery and Rimoin's Principles and Practice of Medical Genetics, (ed 3) Vols I and II. New York, NY, Churchill-Livingstonm, 1997
  4. Scriver CR, Beaudet AL, Sly WS, et al: The Metabolic and Molecular Bases of Inherited Disease (ed 8) Vols I–IV. New York, NY, McGraw-Hill, 2001
  5. Burton BK: Inborn errors of metabolism in infancy: A guide to diagnosis. Pediatrics 102(E69), 1998
  6. Leonard JV, Morris AAM: Inborn errors of metabolism around time of birth. Lancet 583-587, 2000
  7. Millington DS: Tandem mass spectrometry in clinical diagnosis, in Blau N, Duran M, Blaskovics ME et al (eds): Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases (ed 2). Berlin, Germany, Springer, 2003, pp 57–85
  8. Carson NAJ: Non-ketotic hyperglycinemia: A review of 70 patients. J Inherited Metab Dis 2(Suppl):126–138, 1982
  9. Goldfischer S, Moore CL, Johnson A, et al: Peroxisomal and mitochondrial defects in the cerebro–hepato–renal syndrome. Science 182:62–64, 1973
  10. Wilson GN, Holmes RD, Hajra AK: Peroxisomal disorders: Clinical commentary and future prospects. Am J Med Genet 30:771–792, 1998
  11. Bankier A, Turner M, Hopkins IJ: Pyridoxine dependent seizures: A wider clinical spectrum. Arch Dis Child 58:415–418, 1983
  12. Harding CO, Pillers DM, Steiner RD, et al: Potential for misdiagnosis due to lack of metabolic derangement in combined methylmalonic aciduria/hyperhomocysteinemia (cblC) in the neonate. J Perinatol 23:384–386, 2003
  13. Oh MS, Carroll HJ: The anion gap. N Engl J Med 297:814–817, 1977
  14. Ozand PT, Gascon GG: Organic acidurias: A review. J Child Neurol 6:288–303, 1991
  15. Robinson BH, Taylor J, Sherwood WG: The genetic heterogeneity of lactic acidosis: Occurrence of recognizable inborn errors of metabolism in a pediatric population with lactic acidosis. Pediatr Res 14:956–962, 1980
  16. Blass JP, Cederbaum S, Gibson GE: Clinical and metabolic abnormalities accompany deficiencies in pyruvate oxidation, in Hommes FA (ed): Normal and Pathological Development of Energy Metabolism. New York, NY, Wiley-Liss, 1983, pp 210–250
  17. Stansbie D, Sherriff RJ, Denton RM: Fructose load test: An in vivo screening test designed to assess pyruvate dehydrogenase acitivity and interconversion. J Inherited Metab Dis 1:163–165, 1978
  18. Coude FX, Saudubray JM, DeMaugre F, et al: Dichloroacetate as treatment for congenital lactic acidosis. N Engl J Med 29924:1365–1366, 1978
  19. Munnich A, Rustin P, Rotig A, et al: Clinical aspects of mitochondrial disorders. J Inherited Metab Dis 15:448–455, 1992
  20. Rotig A, Cormier V, Blanche S, et al: Person's marrow-pancreas syndrome: A multisystem mitochondrial disorder in infancy. J Clin Invest 86:1601–1608, 1990
  21. Treem WR, Witzleben CA, Piccoli DA, et al: Medium-chain and long-chain acyl CoA dehydrogenase deficiency: clinical, pathologic and ultrastructural differentiation from Reye's syndrome. Hepatology 6:1270–1278, 1986
  22. Berry GT, Yudkoff M: Segal S: Isovaleric academia: Medical and neurodevelopmental effects of long-term therapy. J Pediatr 113:58– 64, 1988
  23. Fenton WA, Gravel RA, Rosenberg LE: Disorders of propionate and methylmalonate metabolism, in Scriver CR, Beaudet AL, Sly WS et al (eds): The Metabolic and Molecular Bases of Inherited Disease (ed 8). New York, NY, McGraw-Hill, 2001, pp 2165–2194
  24. Matsui SM, Mahoney MJ, Rosenberg LE: The natural history of the inherited methylmalonic acidemias. N Engl J Med 308:857–861, 1983
  25. Sweetman L, Williams JC: Branched chain organic acidurias, in Scriver CR, Beaudet AL, Sly WS et al (eds): The Metabolic and Molecular Bases of Inherited Disease (ed 8). New York, NY, McGraw-Hill, 2001, pp 2125–2164
  26. Hoffmann GF, Feyh P: Organic acid analysis, in Blau N, Duran M, Blaskovics ME et al (eds): Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases (ed 2). Berlin, Germany, Springer, 2003, pp 27–44
  27. Gibson KM, Elpeleg ON, Morton DH, et al: Disorders of leucine metabolism, in Blau N, Duran M, Blaskovics ME et al (eds): Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases (ed 2). Berlin, Germany, Springer, 2003, pp 165–189
  28. Nyhan WL, Gibson KM: Disorders of valine–isoleucine metabolism, in Blau N, Duran M, Blaskovics ME et al (eds): Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases (ed 2). Berlin, Germany, Springer, 2003, pp 191–213
  29. Brusilow SW, Maestri NE: Urea cycle disorders: Diagnosis, pathophysiology and therapy. Adv Pediatr 43:127–170, 1996
  30. Donn SM, Swartz RD, Thoene JG: Comparison of exchange transfusion, peritoneal dialysis and hemodialysis for the treatment of hyperammonemia in an anuric newborn infant. J Pediatr 951:67–70, 1979
  31. Kalloghlian A, Gleispach H, Ozand PT: A patient with propionic academia managed with continuous insulin infusion and total parenteral nutrition. J Child Neurol 7S:88–91, 1992
  32. deSous C, Chalmers RA, Stacey TE, et al: The response of L-carnitine and glycine therapy in isovaleric academia. Eur J Pediatr 144:451–456, 1986
  33. Stumpf DA, Parker WD, Engelini C: Carnitine deficiency, organic acidemias and Reye's syndrome. Neurology 35:1041–1045, 1985
  34. Suglycama N, Matsuda I, Wada Y, et al: Urinary propionylcarnitine analysis for monitoring carnitine supplementation in inherited disorders of propionate metabolism. J Inherited Metab Dis 17:611–615, 1994
  35. Acosta PB, Yannicelli S: Nutrition Support Protocols ed 4. Columbus, Ohio, Ross Products Division, 2001
  36. Thompson GN, Chalmers RA, Walter JH, et al: The use of metronidazole in management of methylmalonic and propionic acidemias. Eur J Pediatr 149:792–796, 1990
  37. Cooper BA, Rosenblatt DS: Inherited defects of vitamin B12 metabolism. Annu Rev Nutr 7:291–320, 1987
  38. Morrow G, Burkel GM: Long term management of a patient with vitamin B12-responsive methylmalonic academia. J Pediatr 96:425-426, 1980
  39. Barsotti RJ: Measurement of ammonia in blood. J Pediatr 138: S11–S20, 2001
  40. Summar M, Tuchman M: Proceedings of a consensus conference for the management of patients with urea cycle disorders. J Pediatr 138:S6–S10, 2001
  41. Green A: When and how should we measure plasma ammonia? Annu Clin Biochem 25:99–209, 1988
  42. Ballard RA, Vinocur B, Reynolds JW, et al: Transient hyperammonemia of the preterm infant. N Engl J Med 299:920–925, 1978
  43. Coude FX, Ogier H, Marsac C, et al: Secondary citrullinemia with hyperammonemia in four neonatal cases of pyruvate carboxylase deficiency. Pediatrics 68:914, 1981
  44. Burton BK: Urea cycle disorders. Clin Liver Dis 4:815–830, 2000
  45. Saudubray JM, Charpentier C: Clinical phenotypes: diagnosis/ algorithms, in Scriver CR, Beaudet AL, Sly WS et al (eds): Metabolic and Molecular Bases of Inherited Disease (ed 8). New York, NY, McGraw-Hill, 2001, pp 1327–1403
  46. Brusilow SW, Horwich AL: Urea cycle enzymes, in Scriver CR, Beaudet AL, Sly WS et al (eds): Metabolic and Molecular Bases of Inherited Disease (ed 8). New York, NY, McGraw-Hill, 2001, pp 1909– 1964
  47. Sim KG, Hammond J, Wilcken B: Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders. Clin Chim Acta 323: 37–58, 2002
  48. Nyhan W, Ozand PT: Pyruvate carboxylase deficiency, in Atlas of Metabolic Disease. New York, NYpp. 265-272, Chapman & Hall, 1998
  49. Batshaw ML, Thomas GH, Brusilow SW: New approaches to the diagnosis and treatment of inborn errors of urea synthesis. Pediatrics 68:290–297, 1981
  50. Bachmann C, Colombo JP: Diagnostic value of orotic acid excretion in heritable disorders of the urea cycle and in hyperammonemia due to organic acidurias. Eur J Pediatr 134:109–113, 1980
  51. Coomes MW: Amino acid metabolism, in Devlin TM (ed): Biochemistry with Clinical Correlations (ed 5). New York, NY, Wiley-Liss, 2002, pp 779–821
  52. Bachmann C: Inherited hyperammonemias, in Blau N, Duran M, Blaskovics ME, et al (eds.): Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases (ed 2). Berlin, Germany, Springer, 2003, pp 261–276
  53. Inoue E, Loura M, Saheki T, et al: Abnormality of citrulline synthesis in liver mitochondria from patients with hyperornithinaemia, hyperammonaemia and homocirtullinuria. J Inherited Metab Dis 10:227– 280, 1987
  54. Nyhan W, Ozand PT: Ornithine transcarbamylase deficiency, in Atlas of Metabolic Disease. New York, NYpp 168-177, Chapman & Hall, 1998
  55. Buist NRM, Kennaway NG, Hepburn CA, et al: Citrullinemia: Investigation and treatment over a four year period. J Pediatr 85:208– 214, 1974
  56. Nyhan WL, Sakati NO: Argininosuccinic acidura, in Diagnostic Recognition of Genetic Disease. Philadelphia, PApp 165-167, Lea & Febiger, 1987
  57. Jorda A, Rubio V, Portoles M, et al: A new case of arginase deficiency in a Spanish male. J Inherited Metab Dis 9:393–397, 1986
  58. Braga AC, Vilarinho L, Ferreira E, et al: Hyperargininemia presenting as persistent neonatal jaundice and hepatic cirrhosis. J Pediatr Gastoenterol Nutr 24:218–221, 1997
  59. Picker JD, Puga AC, Leve HL, et al: Arginase deficiency with lethal neonatal expression: Evidence for the glutamine hypothesis of cerebral edema. J Pediatr 142:349–352, 2003
  60. Summar M: Current strategies for the management of neonatal urea cycle disorders. J Pediatr 138:S30–S39, 2001
  61. Batshaw ML, Brusilow SW: Treatment of hyperammonemic coma caused by inborn errors of urea synthesis. J Pediatr 97:893–900, 1980
  62. Brusilow SW, Valle DL, Batshaw M: New pathways of nitrogen excretion in inborn errors of urea synthesis. Lancet 2:452–454, 1979
  63. Batshaw ML: Sodium benzoate and arginine: Alternative pathway therapy in inborn errors of urea synthesis. Clin Biol Res 127:69–83, 1983
  64. Green TP, Marchessault RP, Freese DK: Disposition of sodium benzoate in newborn infants with hyperammonemia. J Pediatr 102:785– 790, 1983
  65. Brusilow SW: Arginine, an indispensable amino acid for patients with inborn errors of urea synthesis. J Clin Invest 74:2144–2148, 1984
  66. Kline JJ, Hug G, Schubert WK, et al: Arginine deficiency syndrome: Its occurrence in carbamyl phosphate synthetase deficiency. Am J Dis Child 135:437–442, 1981
  67. Brusilow SW, Batshaw ML: Arginine therapy of argininosuccinase deficiency. Lancet 1:124–127, 1979
  68. Acosta PB, Yannicelli S: Protocol 24: Urea cycle disorders in Nutrition Support Protocols (ed 4) Columbus, Ohio: Ross Products Division, 2001, pp 418-432
  69. Leonard JV: The nutritional management of urea cycle disorders. J Pediatr 138:S40–S45, 2001
  70. Msall M, Batshaw ML, Suss R, et al: Neurologic outcome in children with inborn errors of urea synthesis. N Engl J Med 310:1500– 1505, 1984
  71. Maestri NE, Clissold DB, Brusilow SW: Long term survival of patients with argininosuccinate synthetase deficiency. J Pediatr 127:929– 935, 1995
  72. Nyhan WL, Ozand PT: Orthinthine transcarbamylase deficiency, in Atlas of Metabolic Diseases. London, UKpp 168-177, Chapman & Hall, 1998
  73. Todo S, Starzl Tel Tzakis A, et al: Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology 15:419–422, 1992
  74. Hasegawa T, Tzakis AG, Todo S, et al: Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy. J Pediatr Surg 30:863–865, 1995
  75. Saudubray JM, Touti G, Gelonlay P, et al: Liver transplantation in urea cycle disorders. Eur J Pediatr 158(Suppl 2):S55–S59, 1999
  76. Dunn S, Weintraub W, Vinocur CD, et al: Is age less than 1 year a high risk category for orthotopic liver transplantation? J Pediatr Surg 28:1048–1050, 1993
  77. Van der Werf WJ, D'Alessandro AM, Knechtle SJ, et al: Infant pediatric liver transplantation results equal those for older pediatric patients. J Pediatr Surg 33:20–23, 1998
  78. Demarquoy J: Retroviral-mediatred gene therapy for the treatment of citullinemia: Transfer and expression of argininosuccinate synthetase in human hemopoietic cells. Experientia 49:345–348, 1993
  79. Kiwaki K, Kanegae Y, Saito I, et al: Correction of ornithine transcarbamylase deficiency in adult spf (ash) mice and in OTC-deficient human hepatocytes with recombinant adenoviruses bearing the CAG promoter. Hum Gene Ther 7:821–830, 1996
  80. Batshaw ML, Robinson MB, Ye X, et al: Correction of ureagenesis after gene transfer in an animal model and after liver transplantation in humans with ornithine transcarbamylase deficiency. Pediatr Res 47: 588–593, 1999
  81. Jones SN, Grompe M, Munir MI, et al: Ectopic correction of ornithine transcarbamylase deficiency in sparse fur mice. J Biol Chem 265:14684–14690, 1990
  82. Patejunas G, Lee B, Dennis JA, et al: Evaluation of gene therapy for citrullinaemia using murine and bovine models. J Inherited Metab Dis 21(Suppl 1):138–150, 1998
  83. Batshaw ML, Wilson JM, Raper S, et al: Recombinant adenovirus gene transferin adults with partial ornithine transcarbamylase deficiency (OTCD). Human Gene Therapy 10:2419–2437, 1999
  84. Kronick JB, Scriver CR, Goodyear RP, et al: A perimortem protocol for suspected genetic disease. Pediatrics 71:960–963, 1983
  85. Helweg-Larsen K: Postmortem protocol. Acta Paediatr 389(Suppl):77–79, 1993
  86. Steiner RD, Cederbaum SD: Laboratory evaluation of urea cycle disorders. J Pediatr 138:S21–S29, 2001
  87. Rashed MS, Ozard PTl, Bennett J, et al: Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile. Clin Chem 41:1109–1114, 1995
  88. Bennett MJ, Ragni MC, Hood I, et al: Comparison of post-mortem urinary and vitreous humour organic acids. Am Clin Biochem 29:541–545, 1999